184 related articles for article (PubMed ID: 29781036)
1. Correlation between HGF/c-Met and Notch1 signaling pathways in human gastric cancer cells.
Huang KH; Sung IC; Fang WL; Chi CW; Yeh TS; Lee HC; Yin PH; Li AF; Wu CW; Shyr YM; Yang MH
Oncol Rep; 2018 Jul; 40(1):294-302. PubMed ID: 29781036
[TBL] [Abstract][Full Text] [Related]
2. The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2.
Yeh TS; Wu CW; Hsu KW; Liao WJ; Yang MC; Li AF; Wang AM; Kuo ML; Chi CW
Cancer Res; 2009 Jun; 69(12):5039-48. PubMed ID: 19491270
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases.
Wang C; Xi W; Ji J; Cai Q; Zhao Q; Jiang J; Zhou C; Shi M; Zhang H; Zhu Z; Zhang J
Int J Med Sci; 2020; 17(13):1946-1955. PubMed ID: 32788873
[TBL] [Abstract][Full Text] [Related]
4. Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression.
Hsu KW; Hsieh RH; Huang KH; Fen-Yau Li A; Chi CW; Wang TY; Tseng MJ; Wu KJ; Yeh TS
Carcinogenesis; 2012 Aug; 33(8):1459-67. PubMed ID: 22581828
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
6. COX-2 regulates Snail expression in gastric cancer via the Notch1 signaling pathway.
Ye Y; Liu M; Yuan H; Ning S; Wang Y; Chen Z; Ji R; Guo Q; Li Q; Zhou Y
Int J Mol Med; 2017 Aug; 40(2):512-522. PubMed ID: 28586004
[TBL] [Abstract][Full Text] [Related]
7. Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
Ahn SY; Kim J; Kim MA; Choi J; Kim WH
Anticancer Res; 2017 Mar; 37(3):1127-1138. PubMed ID: 28314274
[TBL] [Abstract][Full Text] [Related]
8. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer.
Piazzi G; Fini L; Selgrad M; Garcia M; Daoud Y; Wex T; Malfertheiner P; Gasbarrini A; Romano M; Meyer RL; Genta RM; Fox JG; Boland CR; Bazzoli F; Ricciardiello L
Oncotarget; 2011 Dec; 2(12):1291-301. PubMed ID: 22249198
[TBL] [Abstract][Full Text] [Related]
10. TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma.
Zhang T; Liang L; Liu X; Wu JN; Chen J; Su K; Zheng Q; Huang H; Liao GQ
J Oral Pathol Med; 2016 Aug; 45(7):486-93. PubMed ID: 26764364
[TBL] [Abstract][Full Text] [Related]
11. Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor.
Chen JH; Wu CW; Kao HL; Chang HM; Li AF; Liu TY; Chi CW
Cancer Lett; 2006 Aug; 239(2):263-70. PubMed ID: 16243430
[TBL] [Abstract][Full Text] [Related]
12. HGF/MET signaling promotes glioma growth via up-regulation of Cox-2 expression and PGE2 production.
Zhao Y; Sun Y; Zhang H; Liu X; Du W; Li Y; Zhang J; Chen L; Jiang C
Int J Clin Exp Pathol; 2015; 8(4):3719-26. PubMed ID: 26097553
[TBL] [Abstract][Full Text] [Related]
13. Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
Hsu KW; Fang WL; Huang KH; Huang TT; Lee HC; Hsieh RH; Chi CW; Yeh TS
Oncotarget; 2016 Jun; 7(25):38036-38051. PubMed ID: 27191259
[TBL] [Abstract][Full Text] [Related]
14. MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.
Chen CT; Kim H; Liska D; Gao S; Christensen JG; Weiser MR
Mol Cancer Ther; 2012 Mar; 11(3):660-9. PubMed ID: 22238368
[TBL] [Abstract][Full Text] [Related]
15. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
Sun HW; Wu C; Tan HY; Wang QS
Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
[TBL] [Abstract][Full Text] [Related]
17. SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling.
Qin H; Yang Y; Jiang B; Pan C; Chen W; Diao W; Ding M; Cao W; Zhang Z; Chen M; Gao J; Zhao X; Qiu X; Guo H
FEBS J; 2021 Sep; 288(18):5406-5429. PubMed ID: 33705609
[TBL] [Abstract][Full Text] [Related]
18. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
[TBL] [Abstract][Full Text] [Related]
19. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis.
Ding X; Ji J; Jiang J; Cai Q; Wang C; Shi M; Yu Y; Zhu Z; Zhang J
Cell Death Dis; 2018 Aug; 9(9):867. PubMed ID: 30158543
[TBL] [Abstract][Full Text] [Related]
20. Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas.
Park WS; Oh RR; Kim YS; Park JY; Shin MS; Lee HK; Lee SH; Yoo NJ; Lee JY
APMIS; 2000 Mar; 108(3):195-200. PubMed ID: 10752688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
